FI71930C - Foerfarande foer framstaellning av 1,5-disubstituerad hydantoin med aggregation av blodkroppar foerhindrande verkan. - Google Patents
Foerfarande foer framstaellning av 1,5-disubstituerad hydantoin med aggregation av blodkroppar foerhindrande verkan. Download PDFInfo
- Publication number
- FI71930C FI71930C FI771763A FI771763A FI71930C FI 71930 C FI71930 C FI 71930C FI 771763 A FI771763 A FI 771763A FI 771763 A FI771763 A FI 771763A FI 71930 C FI71930 C FI 71930C
- Authority
- FI
- Finland
- Prior art keywords
- group
- formula
- hydantoin
- compound
- diethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
- C07D233/78—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2287776 | 1976-06-03 | ||
| GB2287776 | 1976-06-03 | ||
| GB5034076 | 1976-12-02 | ||
| GB5034076 | 1976-12-02 | ||
| GB1214577 | 1977-03-23 | ||
| GB1214577 | 1977-03-23 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI771763A FI771763A (fi) | 1977-12-04 |
| FI71930B FI71930B (fi) | 1986-11-28 |
| FI71930C true FI71930C (fi) | 1987-03-09 |
Family
ID=27256793
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI771763A FI71930C (fi) | 1976-06-03 | 1977-06-02 | Foerfarande foer framstaellning av 1,5-disubstituerad hydantoin med aggregation av blodkroppar foerhindrande verkan. |
Country Status (12)
| Country | Link |
|---|---|
| JP (1) | JPS52151168A (es) |
| CA (1) | CA1176261A (es) |
| CH (3) | CH645631A5 (es) |
| DE (1) | DE2724948A1 (es) |
| DK (1) | DK244577A (es) |
| ES (5) | ES459412A1 (es) |
| FI (1) | FI71930C (es) |
| FR (1) | FR2362839A1 (es) |
| HU (1) | HU183046B (es) |
| NL (1) | NL7706064A (es) |
| NZ (1) | NZ184281A (es) |
| SE (2) | SE446336B (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1602188A (en) * | 1977-12-01 | 1981-11-11 | Wellcome Found | Hydantoin derivatives |
| AU527959B2 (en) * | 1977-09-05 | 1983-03-31 | Wellcome Foundation Limited, The | Hydantoin derivatives |
| DK543178A (da) * | 1977-12-01 | 1979-06-02 | Wellcome Found | Thiodydantoinderivater |
| DE2963795D1 (en) * | 1978-01-23 | 1982-11-11 | Beecham Group Plc | Hydantoins and thiohydantoins, method for their preparation and pharmaceutical compositions containing them |
| EP0004723A1 (en) * | 1978-03-30 | 1979-10-17 | Beecham Group Plc | Deoxyhydantoins, processes for their preparation and pharmaceutical compositions containing them |
| GB1599740A (en) * | 1978-05-31 | 1981-10-07 | Wellcome Found | Hydantoin derivatives |
| AU4778279A (en) * | 1978-06-15 | 1979-12-20 | Beecham Group Limited | Prostaglandin analogues |
| IL57504A0 (en) * | 1978-06-15 | 1979-10-31 | Beecham Group Ltd | Prostagandin analogues,their preparation and pharmaceutical compositions containing |
| EP0006352A1 (en) * | 1978-06-15 | 1980-01-09 | Beecham Group Plc | Hydantoins and thiohydantoins, process for their preparation and pharmaceutical compositions containing them |
| EP0007180B1 (en) * | 1978-06-15 | 1983-03-30 | Beecham Group Plc | Prostaglandin analogue triazole derivatives, processes for their preparation and a pharmaceutical composition containing them |
| IL59065A0 (en) * | 1979-01-18 | 1980-05-30 | Beecham Group Ltd | Hydantoin derivatives,their preparation pharmaceutical compositons containing them |
| JPS55151569A (en) * | 1979-05-09 | 1980-11-26 | Wellcome Found | Optically active heterocyclic compounds* their synthesis and medical blend containing them |
| US4684735A (en) * | 1985-07-01 | 1987-08-04 | Stauffer Chemical Company | Promotion of raney nickel hydrogenation catalyst |
| JP3022878U (ja) * | 1995-08-18 | 1996-04-02 | 有限会社春江加工 | ミニディスク用ケース |
| MXPA04005123A (es) * | 2001-11-30 | 2005-02-17 | Lilly Co Eli | Agonistas del receptor activado por proliferador de peroxisoma. |
| CA2528179C (en) * | 2003-06-06 | 2013-10-22 | Allergan, Inc. | Piperidinyl prostaglandin e analogs |
| US7179820B2 (en) * | 2003-06-06 | 2007-02-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1524818A (en) * | 1974-11-29 | 1978-09-13 | Beecham Group Ltd | 12-azaprostaglandins |
-
1977
- 1977-06-02 FR FR7716849A patent/FR2362839A1/fr active Granted
- 1977-06-02 HU HU77WE560A patent/HU183046B/hu unknown
- 1977-06-02 NL NL7706064A patent/NL7706064A/xx not_active Application Discontinuation
- 1977-06-02 ES ES459412A patent/ES459412A1/es not_active Expired
- 1977-06-02 DK DK244577A patent/DK244577A/da not_active Application Discontinuation
- 1977-06-02 CH CH679677A patent/CH645631A5/de not_active IP Right Cessation
- 1977-06-02 FI FI771763A patent/FI71930C/fi not_active IP Right Cessation
- 1977-06-02 SE SE7706428A patent/SE446336B/xx unknown
- 1977-06-02 NZ NZ184281A patent/NZ184281A/xx unknown
- 1977-06-02 JP JP6525277A patent/JPS52151168A/ja active Granted
- 1977-06-02 DE DE19772724948 patent/DE2724948A1/de not_active Ceased
- 1977-06-02 CA CA000280455A patent/CA1176261A/en not_active Expired
-
1978
- 1978-06-01 ES ES470428A patent/ES470428A1/es not_active Expired
-
1979
- 1979-02-28 ES ES478156A patent/ES478156A1/es not_active Expired
- 1979-06-28 ES ES482010A patent/ES482010A1/es not_active Expired
-
1980
- 1980-03-25 ES ES489883A patent/ES489883A0/es active Granted
-
1982
- 1982-05-19 SE SE8203161A patent/SE8203161L/sv not_active Application Discontinuation
-
1984
- 1984-02-07 CH CH576/84A patent/CH647511A5/de not_active IP Right Cessation
- 1984-02-07 CH CH57784A patent/CH646426A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES459412A1 (es) | 1978-11-01 |
| ES8103057A1 (es) | 1981-02-16 |
| ES489883A0 (es) | 1981-02-16 |
| CH646426A5 (en) | 1984-11-30 |
| NL7706064A (nl) | 1977-12-06 |
| HU183046B (en) | 1984-04-28 |
| SE7706428L (sv) | 1977-12-04 |
| ES470428A1 (es) | 1979-09-01 |
| FR2362839B1 (es) | 1980-02-01 |
| DK244577A (da) | 1977-12-04 |
| DE2724948A1 (de) | 1977-12-15 |
| CA1176261A (en) | 1984-10-16 |
| CH645631A5 (en) | 1984-10-15 |
| JPS52151168A (en) | 1977-12-15 |
| NZ184281A (en) | 1980-04-28 |
| SE8203161L (sv) | 1982-05-19 |
| FR2362839A1 (fr) | 1978-03-24 |
| SE446336B (sv) | 1986-09-01 |
| ES478156A1 (es) | 1979-11-01 |
| JPS6222986B2 (es) | 1987-05-20 |
| FI71930B (fi) | 1986-11-28 |
| FI771763A (fi) | 1977-12-04 |
| CH647511A5 (en) | 1985-01-31 |
| ES482010A1 (es) | 1980-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI71930C (fi) | Foerfarande foer framstaellning av 1,5-disubstituerad hydantoin med aggregation av blodkroppar foerhindrande verkan. | |
| US6166005A (en) | Heterocyclic metalloprotease inhibitors | |
| US5646167A (en) | Arylsulfonamido-substituted hydroxamix acids | |
| US5672615A (en) | Arylsulfonamido-substituted hydrodxamic acids | |
| US5506242A (en) | Arylsufonamido-substituted hydroxamic acids | |
| US5455258A (en) | Arylsulfonamido-substituted hydroxamic acids | |
| US4225609A (en) | Interphenylene 9-thia-11-oxo-12-aza-prostanoic acids | |
| US5883106A (en) | 5-lipoxygenase inhibitors | |
| US7592364B2 (en) | Substituted gamma lactams as therapeutic agents | |
| US6015912A (en) | Spirocyclic containing hydroxamic acids useful as metalloprotease inhibitors | |
| FR2698873A1 (fr) | Benzocycloheptènes, benzoxépines et benzothiépines activateurs des canaux potassiques, procédé de préparation, composition pharmaceutique les contenant. | |
| US4486443A (en) | Hydantoin derivatives and pharmaceutical use | |
| RU2136666C1 (ru) | Гетероциклическое соединение, фармацевтическая композиция и способ ингибирования 5-липоксигеназы | |
| IE67507B1 (en) | Cyclopentane derivatives process for their production and their pharmaceutical use | |
| EP0001238B1 (en) | Hydantoin derivatives, their synthesis, pharmaceutical formulations and intermediates in their preparation | |
| US6124338A (en) | Imidazoles with serotonin receptor binding activity | |
| US4337262A (en) | Hydantoin derivatives, pharmaceutical compounds and methods of use | |
| US4859691A (en) | Certain 1,2-benzisoxazole derivatives | |
| US4946862A (en) | Thiophene derivative and process for preparing the same | |
| US4262128A (en) | Nitrogen heterocycles | |
| US5849751A (en) | Amides and sulphonamides of benzylamines having heterocyclic substituents | |
| US4298745A (en) | Hydantoin derivatives | |
| JPH0641068A (ja) | インドリン誘導体およびアレルギー性または炎症性疾患治療用組成物 | |
| SU1060107A3 (ru) | Способ получени производных гидантоина или их солей | |
| GB1595695A (en) | Hydantoin analogues |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: THE WELLCOME FOUNDATION LIMITED |